Grant: Canada Research Chairs
University of Guelph
$120,000.00
Proteomics of Fungal Disease in One Health
FY 2023-24
Summary
Fungal diseases greatly impact the world around us, including our environment, food, and health. Beginning with the food we eat, infection of cereal crops with fungal pathogens can cause devastating disease (e.g., Fusarium head blight), which reduces grain quality and yield. Additionally, fungal pathogens produce mycotoxins, which can accumulate within the grains to cause vomiting and toxic responses within animals and humans upon consumption. To mitigate the impact of fungal disease in the field, fungicides are applied annually; however, this strategy is not 100% effective and does not prevent the contamination of grains with mycotoxins if infection persists. Moreover, the release of fungicides into the environment can expose environmental fungi, such as Cryptococcus neoformans, to low levels of the antifungal agent (e.g., azoles) and promote the evolution of resistance towards our limited repertoire of antifungal drugs (e.g., fluconazole). The subsequent development of resistance prevents the effective treatment of disease (e.g., cryptococcosis) in animals and humans, increasing morbidity and mortality rates around the globe. To address these challenges, my Canada Research Chair program in Proteomics of Fungal Disease in One Health uses an innovative approach to explore the interconnectivity among environment, animal, and human health to improve global food security and expand our understanding of factors driving antifungal resistance. The objectives of my research program include exploring mechanisms of mycotoxin degradation in Fusarium head blight of wheat to reduce the burden of mycotoxin contamination in cereal grains (Obj. 1) and defining mechanisms conferring antifungal resistance in C. neoformans to propose new strategies for combatting the increasing rates of resistance. My approach is universal and readily adaptable to exploring host responses towards other fungal mycotoxins (e.g., aflatoxin), mechanisms of resistance against other antifungal drugs (e.g., Amphotericin B), and with consideration of diverse fungal pathogens (e.g., Candida albicans). Together, my research program aims to balance the need for fungicide applications in the field with the deleterious downstream implications on environmental health to benefit over one billion people around the world annually.
Program
Canada Research Chairs
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
CRC-2022-00157
Name nom
Geddes-McAlister, Jennifer
Department département
Molecular and Cellular Biology - University of Guelph
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2022
Award amount
120000
Program id
CRC
Program name en
Canada Research Chairs
Program name fr
Chaires de recherche du Canada
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
9998
Committee name en
Canada Research Chair Selection Committee
Committee name fr
Comité de sélection des Chaires de recherche du Canada
Area of application code
10000
Area of application group en
The socioeconomic objective available
Area of application group fr
L'objectif socioéconomique disponible
Area of application en
The socioeconomic objective available
Area of application fr
L'objectif socioéconomique disponible
Research subject code
10000
Research subject group en
The field of research available
Research subject group fr
The field of research available
Research subject en
Le domaine de recherche disponible
Research subject fr
Le domaine de recherche disponible
Field of research list codes
RDF1060605
Field of research list names en
Epigenetics and epigenomics
Field of research list names fr
Épigénétique et épigénomique
Socioeconomic objective list codes
RDS10204
Socioeconomic objective list names en
Control of pests, diseases and exotic species
Socioeconomic objective list names fr
Lutte contre les ravageurs, les maladies et les espèces exotiques
Application title
Proteomics of Fungal Disease in One Health
Keyword
Fusarium head blight; Antifungal resistance; Mass spectrometry-based proteomics; One Health; Fungal disease; Cereal crops; Systems biology; Cryptococcus neoformans; Bioinformatics
Application summary
Fungal diseases greatly impact the world around us, including our environment, food, and health. Beginning with the food we eat, infection of cereal crops with fungal pathogens can cause devastating disease (e.g., Fusarium head blight), which reduces grain quality and yield. Additionally, fungal pathogens produce mycotoxins, which can accumulate within the grains to cause vomiting and toxic responses within animals and humans upon consumption. To mitigate the impact of fungal disease in the field, fungicides are applied annually; however, this strategy is not 100% effective and does not prevent the contamination of grains with mycotoxins if infection persists. Moreover, the release of fungicides into the environment can expose environmental fungi, such as Cryptococcus neoformans, to low levels of the antifungal agent (e.g., azoles) and promote the evolution of resistance towards our limited repertoire of antifungal drugs (e.g., fluconazole). The subsequent development of resistance prevents the effective treatment of disease (e.g., cryptococcosis) in animals and humans, increasing morbidity and mortality rates around the globe. To address these challenges, my Canada Research Chair program in Proteomics of Fungal Disease in One Health uses an innovative approach to explore the interconnectivity among environment, animal, and human health to improve global food security and expand our understanding of factors driving antifungal resistance. The objectives of my research program include exploring mechanisms of mycotoxin degradation in Fusarium head blight of wheat to reduce the burden of mycotoxin contamination in cereal grains (Obj. 1) and defining mechanisms conferring antifungal resistance in C. neoformans to propose new strategies for combatting the increasing rates of resistance. My approach is universal and readily adaptable to exploring host responses towards other fungal mycotoxins (e.g., aflatoxin), mechanisms of resistance against other antifungal drugs (e.g., Amphotericin B), and with consideration of diverse fungal pathogens (e.g., Candida albicans). Together, my research program aims to balance the need for fungicide applications in the field with the deleterious downstream implications on environmental health to benefit over one billion people around the world annually.